NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

10057	Companies
205564	Keywords
135810	Articles
108991	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 11/15/2024 at 12:30, 1 year 4 months ago

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID
NanoViricides, Inc. files Quarterly Report on Form 10-Q with the SEC, highlights financial results and progress on NV-387 antiviral drug for various infections including MPox and RSV

NanoViricides NV-387 Quarterly Report SEC Filing Antiviral Drug
BRIEF

published on 11/04/2024 at 06:05, 1 year 4 months ago

NanoViricides Presents at Spartan Capital Investors Conference 2024

NanoViricides NV-387 Antiviral Nanomedicines Spartan Capital Conference Dr. Anil R. Diwan
BRIEF

published on 11/04/2024 at 06:05, 1 year 4 months ago

NanoViricides présente sa nouvelle technologie à la conférence Spartan Capital Investors 2024

NanoViricides NV-387 Nanomédicaments Antiviraux Conférence Sur La Capitale Spartiate Dr Anil R. Diwan
PRESS RELEASE

published on 11/04/2024 at 06:00, 1 year 4 months ago

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am
NanoViricides, Inc. to present corporate update at Spartan Capital Investors Conference on NV-387 antiviral drug development with strong market potential

NV-387 NanoViricides Inc. Market Potential Antiviral Drug Spartan Capital Investors Conference
BRIEF

published on 10/22/2024 at 12:35, 1 year 4 months ago

NanoViricides President to Present at PODD Conference

NanoViricides NV-387 Drug Delivery PODD Conference Antiviral Treatments
BRIEF

published on 10/22/2024 at 12:35, 1 year 4 months ago

Le président de NanoViricides fera une présentation à la conférence PODD

NanoViricides NV-387 Administration De Médicaments Conférence PODD Traitements Antiviraux
PRESS RELEASE

published on 10/22/2024 at 12:30, 1 year 4 months ago

NanoViricides President Dr. Diwan to Present at the PODD Conference
NanoViricides announces President Dr. Anil R. Diwan to speak at PODD Conference about revolutionary antiviral nanomedicines. Conference focuses on drug delivery partnerships and trends

NanoViricides Drug Delivery Antiviral Nanomedicines PODD Conference Anil R. Diwan
BRIEF

published on 10/15/2024 at 12:35, 1 year 5 months ago

Innovative Antiviral Technology Discussed in Recent NanoViricides Podcast

NanoViricides NV-387 Antiviral Treatment Phase II Trials Nanomedicine Technology
BRIEF

published on 10/15/2024 at 12:35, 1 year 5 months ago

Une technologie antivirale innovante évoquée dans le récent podcast NanoViricides

NanoViricides NV-387 Traitement Antiviral Essais De Phase II Technologie De La Nanomédecine
PRESS RELEASE

published on 10/15/2024 at 12:30, 1 year 5 months ago

NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
NanoViricides, Inc. announces interview with Dr. Diwan discussing revolutionary broad-spectrum antiviral clinical drug candidate NV-387 and innovative nanoviricide technology platform

NV-387 Clinical Trials NanoViricides Inc. Antiviral NanoViricides Technology

Accesswire

Published on 03/20/2026 at 13:30, 6 hours 15 minutes ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 7 hours 15 minutes ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 12:00, 7 hours 45 minutes ago

Organto Foods Inc. Announces Marketing Engagements with VSA Capital Limited and Venture Liquidity Partner Ltd.
Published on 03/20/2026 at 03:10, 16 hours 35 minutes ago

Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 19 hours 25 minutes ago

Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A

View all ACCESSWIRE

EQS Group

Published on 03/20/2026 at 19:06, 39 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/20/2026 at 19:00, 45 minutes ago

PATRIMOINE ET COMMERCE: COMMUNIQUE DE MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL CONTENANT LE RAPPORT FINANCIER ANNUEL RELATIF A L’EXERCICE 2025
Published on 03/20/2026 at 18:29, 1 hour 16 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Full year figures in line with guidance – reduced earnings in Q4 2025/26
Published on 03/20/2026 at 17:50, 1 hour 54 minutes ago

Funding Circle Holdings plc: Transaction in Own Shares
Published on 03/20/2026 at 17:47, 1 hour 58 minutes ago

EQS-Adhoc: ZhongDe Waste Technology AG: Suspension of the revocation of the admission of ZhongDe Waste Technology AG shares to trading on the regulated market (General Standard)

Les Echos

Published on 03/20/2026 at 19:00, 45 minutes ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 45 minutes ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 hour 30 minutes ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 hour 30 minutes ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE